Committed to Neuroscience
Advancing the Future of Neurological Care
Teva is committed to addressing areas of high unmet medical need, exploring innovative treatments and driven by one purpose - to help support patients and the people who care for them.
Living with severe mental illness (SMI), including bipolar disorder, depression and schizophrenia, has a profound individual impact in terms of physical and emotional wellbeing, and affects the wider economy in terms of work productivity loss and long-term disability. 01 However, in addition to the ‘visible’ impact of SMI , there is also a significant ‘invisible’ burden as a consequence of the stigma that may be experienced by people living with these conditions.
Learn more about the physical and emotional burden of schizophrenia, not only on those diagnosed with the condition but also on those around them, their community and the wider economy.
White Paper: Overcoming Barriers for People with Schizophrenia
Teva’s new White Paper in Europe: Overcoming Barriers for People with Schizophrenia to Enable them to Connect, Contribute, and Thrive in an Open Society’ explores the physical and emotional burden of living with schizophrenia. Reading about the impact of the stigma associated with this condition and the need to change our pre-conceived ideas about mental illness.
Executive Summary: Ending the Exclusion
Schizophrenia remains one of the most misunderstood and stigmatized of all mental health conditions.
Infographic: Rewriting Luca’s Story
Imagine Luca, a 40-year-old man living with schizophrenia. His daily life is a quiet ongoing battle, and a mirror to millions.
Neurological Conditions Take So Much: Teva is Working to Give Something Back
“The consequences of neurological disease affect so much more than the nervous system. This feeds our relentless quest for ‘what’s next’ in innovative treatments”
